Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder
Ayal Schaffer(University of Toronto), Lakshmi N. Yatham(University of British Columbia), Nancy Diazgranados(National Institute on Alcohol Abuse and Alcoholism), Kyooseob Ha(Seoul National University), Erkki Isometsä(University of Helsinki), Catherine Reis(Sunnybrook Health Science Centre), Tina R. Goldstein(University of Pittsburgh), Anthony Levitt(University of Toronto), Abraham Weizman(Geha Mental Health Center), Lars Vedel Kessing(Copenhagen University Hospital), Leonardo Tondo(Harvard University), Annette L. Beautrais(Unknown), Mark Sinyor(Sunnybrook Health Science Centre), Carlos A. Zarate(National Institute of Mental Health), Frederick Cassidy(Universidade Federal do Rio Grande do Sul), Doris Hupfeld Moreno(Universidade de São Paulo), Zoltán Rihmer(Semmelweis University), Gustavo Turecki(Douglas Mental Health University Institute), Jean‐Michel Azorin(Hôpital Sainte-Marguerite), Yuan-Hwa Chou(National Yang Ming Chiao Tung University)
Cited by 178
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Suicide risk and prevention during the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.6k
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
|Bipolar Disorders|2012|1.2k
Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder
|The Canadian Journal of Psychiatry|2016|1.1k